# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-017941
Filing Date
2024-04-04
Accepted
2024-04-04 16:09:10
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | ny20020401x2_defa14a.htm | DEFA14A | 8648
2 |  | ny20020401x2_nc01.jpg | GRAPHIC | 433777
3 |  | ny20020401x2_nc02.jpg | GRAPHIC | 317416
| Complete submission text file | 0001140361-24-017941.txt |  | 1044966

Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14956 | Film No.: 24823222
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)